United States· US:0074-1040_6ff1e6a7-1578-4e78-b34f-eb204b23554c
Survanta
A medicinal product containing beractant, registered in United States by AbbVie Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- BERACTANT
- Manufacturer
- AbbVie Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc1100741040041 VIAL, SINGLE-USE in 1 CARTON (0074-1040-04) / 4 mL in 1 VIAL, SINGLE-USE
- ndc1100741040081 VIAL, SINGLE-USE in 1 CARTON (0074-1040-08) / 8 mL in 1 VIAL, SINGLE-USE
- ndc110074-1040-04
- ndc110074-1040-08
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Beractant in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaSURVANTAABBVIE CORPORATION
- United KingdomSurvanta 200mg/8ml endotracheopulmonary suspension bottlesAbbVie Ltd
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- United Kingdom (Northern Ireland) · Survanta
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1ceef4d1-84f6-4123-aeb8-8d7cd50769bb GET /v1/drugs/1ceef4d1-84f6-4123-aeb8-8d7cd50769bb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ENDOTRACHEAL",
"source": "ndc",
"strength": "25",
"substance": "BERACTANT",
"productndc": "0074-1040",
"dosage_form": "SUSPENSION",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "BLA020032",
"marketing_category": "BLA"
}See everything about beractant.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.